- Home
- / Shenyang Xingqi Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Shenyang Xingqi Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥89.3
2024-10-29
Market Capitalization
¥15.3 B
2024-10-29
Revenue
¥2.4 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 420.3M | 529.1M | 673.4M | 1.0B | 1.2B | 1.4B | 1.9B | 2.4B |
| Cost of goods sold | 119.4M | 145.0M | 185.0M | 225.2M | 265.7M | 332.1M | 421.1M | 466.0M |
| Gross profit | 301.5M | 387.9M | 493.8M | 788.9M | 968.5M | 1.1B | 1.5B | 2.0B |
| Gross profit margin, % | 73.3% | 73.3% | 78.1% | 80.0% | 78.6% | 78.8% | 81.6% | |
| Operating expense total | 252.3M | 305.9M | 338.5M | 487.3M | 675.7M | 777.4M | 1.0B | 1.1B |
| Depreciation and amortization | 35.6M | 40.2M | 46.1M | 57.6M | 65.3M | 79.7M | 93.1M | 102.5M |
| EBITDA | 49.1M | 82.0M | 155.4M | 301.5M | 292.8M | 341.7M | 493.5M | 909.0M |
| EBITDA margin, % | 15.5% | 23.1% | 29.8% | 24.2% | 24.0% | 26.0% | 37.6% | |
| EBIT | 14.3M | 40.3M | 108.8M | 246.5M | 225.6M | 258.8M | 396.0M | 804.5M |
| EBIT margin, % | 7.6% | 16.2% | 24.4% | 18.6% | 18.2% | 20.9% | 33.2% | |
| Interest income | 137.0K | 153.0K | 221.0K | 831.0K | 9.9M | 7.9M | 5.7M | 2.3M |
| Interest expense | 3.1M | 4.5M | 5.9M | 6.0M | 937.0K | 1.4M | 5.7M | 4.4M |
| Pre tax profit | 11.2M | 35.8M | 102.5M | 243.5M | 233.7M | 265.0M | 395.0M | 800.3M |
| Income tax expense | 2.2M | 6.3M | 9.1M | 34.4M | 22.0M | 25.0M | 57.0M | 104.4M |
| Net Income | 9.0M | 29.5M | 93.5M | 209.1M | 211.7M | 240.0M | 338.1M | 695.9M |